Indeed, both pharmacological and genetic inhibition of p53 function can decrease neuroepithelial apoptosis and rescue animal models of TCS (Jones et al., 2008), open neural tube defects (Pani et al., 2002), and HPE (Billington et al., 2011). The gene discussed is TP53; the disease is Treacher-Collins syndrome.